A pilot phase II trial of a synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal residual disease Meeting Abstract


Authors: Cortes, J.; Reuben, J. M.; Scheinberg, D.; Lee, B. N.; Gao, H.; Li, C.; Mazanet, R.; Jones, D.; Kantarjian, H.
Abstract Title: A pilot phase II trial of a synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal residual disease
Meeting Title: 48th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 108
Issue: 11 Pt. 1
Meeting Dates: 2006 Dec 9-12
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2006-11-01
Start Page: 623A
Language: English
ACCESSION: WOS:000242440002717
PROVIDER: wos
PUBMED: 17139767
DOI: 10.1182/blood.V108.11.2196.2196
Notes: --- - Meeting Abstract: 2196 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos"
Altmetric
Citation Impact
MSK Authors